3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Recruiting
4
Unknown
3
Completed
2
Withdrawn
1
Suspended
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Tumor-Agnostic
1
Conditions
Neoplasms
1
Interventions
Specimen Handling
12
Magnetic Resonance Spectroscopy
10
Cyclophosphamide
10
Cisplatin
7
Bevacizumab
7
pembrolizumab
6
Radiosurgery
6
Oxaliplatin
5
Nivolumab
5
Irinotecan
5
Fluorouracil
5
Everolimus
5
Capecitabine
5
Biopsy
5
venetoclax
4
fludarabine
4
S 1 (combination)
4
Prednisone
4
Leucovorin
4
Gemcitabine
4
Etoposide
4
Drug Therapy
4
Doxorubicin
4
Azacitidine
4
fludarabine phosphate
3
Vincristine
3
Taxes
3
Tacrolimus
3
Surveys and Questionnaires
3
Surgical Procedures, Operative
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Suspended
×
OTHER
×
Cell Count
×
Clear all
NCT05887882
2026-04-24
PNOC028
University of California, San Francisco
Phase 1
Suspended
24 enrolled